Norwalk, Connecticut, United States EGS Healthcare Capital Partners is the famous VC, which was founded in 1999. The main office of represented VC is situated in the Norwalk. The fund was located in North America if to be more exact in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical Device, Health Care. Among the most popular portfolio startups of the fund, we may highlight OptiScan Biomedical, Ardais Corporation, Endius. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups.
This EGS Healthcare Capital Partners works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2007. The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2005.
The current fund was established by Stefano Ciampolini, Terry Vance.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the EGS Healthcare Capital Partners, startups are often financed by Advanced Technology Ventures, Venture Capital Fund of New England, Hillman Medical Ventures. The meaningful sponsors for the fund in investment in the same round are NGN Capital, MedVenture Associates, The Carlyle Group. In the next rounds fund is usually obtained by Morgan Stanley Expansion Capital, MedVenture Associates, Wexford Capital.
Related Funds
Funds with similar focus
| Fund Name | Location |
| African Development Bank | Belvédère, Tunis, Tunisia |
| Arpwood Capital | India, Maharashtra, Mumbai |
| ATCO Group | Alberta, Calgary, Canada |
| Cassiopeia Capital Partners | Delaware, Lewes, United States |
| CITRIS Foundry | Berkeley, California, United States |
| CV Catalyst Fund | New York, New York, United States |
| Groupe du Louvre | France, Ile-de-France, Paris |
| Guotai Asset Management | China, Hongkou District |
| Happy Farm Business Accelerator | - |
| Jilin Aodong Medicine | China, Guangdong Province, Huizhou |
| Navigator Technology Ventures | Cambridge, Massachusetts, United States |
| Paulson & Co. | New York, New York, United States |
| Rangos Investments | - |
| Red Apple Group | New York, New York, United States |
| Shanghai Tangsheng Investment Development | China, Shanghai |
| Sphera Funds Management | Israel, Tel Aviv, Tel Aviv District |
| Startup Buddy | Gurgaon, Haryana, India |
| Urbana | City of Edinburgh, Scotland, United Kingdom |
| VLane Capital | Beijing, Beijing, China |
| Waterloo Ventures | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
EKOS Corporation | $26M | 21 Mar 2006 | Washington, United States | ||
Cerexa Inc. | $50M | 23 Aug 2005 | New York, New York, United States | ||
EKOS Corporation | $18M | 18 Feb 2005 | Washington, United States | ||
Alveolus | $10M | 30 Jul 2004 | - | ||
Jazz Pharmaceuticals | $250M | 24 Mar 2004 | Palo Alto, California, United States | ||
Endius | $26M | 26 Mar 2003 | Massachusetts, United States | ||
Ardais Corporation | $33M | 20 Mar 2001 | Massachusetts, United States | ||
CytoLogix | $27M | 29 Jan 2001 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
EKOS Corporation | $26M | 21 Mar 2006 | Washington, United States | ||
Cerexa Inc. | $50M | 23 Aug 2005 | New York, New York, United States | ||
EKOS Corporation | $18M | 18 Feb 2005 | Washington, United States | ||
Alveolus | $10M | 30 Jul 2004 | - | ||
Jazz Pharmaceuticals | $250M | 24 Mar 2004 | Palo Alto, California, United States | ||
Endius | $26M | 26 Mar 2003 | Massachusetts, United States | ||
Ardais Corporation | $33M | 20 Mar 2001 | Massachusetts, United States | ||
CytoLogix | $27M | 29 Jan 2001 | Cambridge, Massachusetts, United States |
